These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38677063)

  • 21. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A comparative study using Donabedian's structure-process-outcome framework.
    Wang Q; Liu S; Nie Z; Zhu Z; Fu Y; Zhang J; Wei X; Yang L; Wei X
    J Glob Health; 2023 Nov; 13():04137. PubMed ID: 37947028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value-Based Pricing in Latin America: How Far Away Are We?
    Mejía A; Gilardino R; Kristensen FB; Garrison LP;
    Value Health Reg Issues; 2018 Dec; 17():219-223. PubMed ID: 30528780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of medicines pricing policies in sub-Saharan Africa: systematic review.
    Koduah A; Baatiema L; de Chavez AC; Danso-Appiah A; Kretchy IA; Agyepong IA; King N; Ensor T; Mirzoev T
    Syst Rev; 2022 Dec; 11(1):257. PubMed ID: 36457058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Financial arrangements for health systems in low-income countries: an overview of systematic reviews.
    Wiysonge CS; Paulsen E; Lewin S; Ciapponi A; Herrera CA; Opiyo N; Pantoja T; Rada G; Oxman AD
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011084. PubMed ID: 28891235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enablers and barriers of maternal and neonatal immunization programs in Latin America.
    Ropero Alvarez AM; Vilajeliu A; Magariños M; Jauregui B; Guzmán L; Whittembury A; Cain E; Garcia O; Montesanos R; Ruiz Matus C;
    Vaccine; 2021 Jul; 39 Suppl 2():B34-B43. PubMed ID: 32943263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries.
    Peacocke EF; Heupink LF; Frønsdal K; Dahl EH; Chola L
    BMJ Open; 2021 Sep; 11(9):e049505. PubMed ID: 34593496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.
    Babar ZU; Lessing C; Mace C; Bissell K
    Pharmacoeconomics; 2013 Nov; 31(11):1063-82. PubMed ID: 24127259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving global access to new vaccines: intellectual property, technology transfer, and regulatory pathways.
    Crager SE
    Am J Public Health; 2014 Nov; 104(11):e85-91. PubMed ID: 25211753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-designing the Mozambique vaccine supply chain to improve access to vaccines.
    Lee BY; Haidari LA; Prosser W; Connor DL; Bechtel R; Dipuve A; Kassim H; Khanlawia B; Brown ST
    Vaccine; 2016 Sep; 34(41):4998-5004. PubMed ID: 27576077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inequitable Distribution of Global Economic Benefits from Pneumococcal Conjugate Vaccination.
    Niyibitegeka F; Russell FM; Jit M; Carvalho N
    Vaccines (Basel); 2024 Jul; 12(7):. PubMed ID: 39066405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cost analysis of producing vaccines in developing countries.
    Munira SL; Hendriks JT; Atmosukarto II; Friede MH; Carter LM; Butler JRG; Clements ACA
    Vaccine; 2019 Feb; 37(9):1245-1251. PubMed ID: 30651198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The problems and promise of vaccine markets in developing countries.
    Batson A
    Health Aff (Millwood); 2005; 24(3):690-3. PubMed ID: 15886160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with the pricing of childhood vaccines in the U.S. public sector.
    Chen W; Messonnier M; Zhou F
    Health Econ; 2018 Feb; 27(2):252-265. PubMed ID: 28660666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global perspectives on vaccine financing.
    Berman S; Giffin RB
    Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines.
    Gorodensky A; Kohler JC
    J Pharm Policy Pract; 2022 Aug; 15(1):50. PubMed ID: 35986397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rotavirus vaccines and vaccination in Latin America.
    Linhares AC; Bresee JS
    Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.